Epirubicin

The recommended starting dose of ELLENCE is 100 to 120 mg/m 2.

Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.

ELLENCE is contraindicated in patients with: Severe myocardial insufficiency, Recent myocardial infarction or severe arrhythmias, or previous treatment with maximum cumulative dose of anthracyclines, Severe persistent drug-induced myelosuppression, Severe hepatic impairment (defined as Child-Pugh Class C or serum bilirubin level greater than 5 mg/dL), Severe hypersensitivity to ELLENCE, other anthracyclines, or anthracenediones, Severe myocardial insufficiency., Recent myocardial infarction., Severe persistent drug-induced myelosuppression., Severe hepatic impairment., Severe hypersensitivity to ELLENCE, other anthracyclines, or anthracenediones.

Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.

Use in Patients with Hepatic Impairment: Monitor serum total bilirubin and AST levels before and during treatment with ELLENCE. In patients with elevated serum AST or serum total bilirubin, dosage reductions or discontinuation may be required., Tumor Lysis Syndrome: Evaluate blood uric acid levels, potassium, calcium, phosphate, and creatinine after initial treatment.

Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.

The following clinically significant adverse reactions are described elsewhere in the labeling: Cardiac Toxicity, Secondary Malignancies, Extravasation and Tissue Necrosis, Severe Myelosuppression, Tumor-Lysis Syndrome, Thrombophlebitis and Thromboembolic Events, Potentiation of Radiation Toxicity and Radiation Recall The most common adverse reactions (≥10%) are leukopenia, neutropenia, anemia, thrombocytopenia, amenorrhea,…

Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.

71 products from 37 makers in the NepalDoc medicine catalog use this generic:

Showing 30 of 71 catalog products. Search the full catalog in the app.

Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.

Store refrigerated between 2°C and 8°C (36°F and 46°F). Do not freeze. Protect from light. Storage of the solution for injection at refrigerated conditions can result in the formation of a gelled product. This gelled product will return to a slightly viscous to mobile solution after 2 to a maximum of 4 hours equilibration at controlled room temperature (15–25°C).

Storage information from the U.S. FDA-approved label.